Stock Track | JD Health Plummets 5.31% Intraday on GLP-1 Drug Sales Regulations and Sector Weakness

Stock Track

05/18

JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare platform.

New regulations that took effect require purchasers of GLP-1 weight loss drugs to present paper prescriptions issued by physical hospitals, invalidating prescriptions from internet hospitals. This has led multiple pharmacies to delist related products from JD and other platforms, directly suppressing the company's online pharmaceutical sales business.

The Internet and Direct Marketing Retail sector faced broad selling pressure, with peers including Ali Health, PA Good Doctor, JD Group, Alibaba, and Meituan also declining, amplifying the downward move in JD Health's shares.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1147798349"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147798349\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147798349?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-18 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147798349","market":"us","top_or_hot":-1,"title":"Stock Track | JD Health Plummets 5.31% Intraday on GLP-1 Drug Sales Regulations and Sector Weakness","media":"Stock Track","content":"<p>JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare platform.</p><p>New regulations that took effect require purchasers of GLP-1 weight loss drugs to present paper prescriptions issued by physical hospitals, invalidating prescriptions from internet hospitals. This has led multiple pharmacies to delist related products from JD and other platforms, directly suppressing the company's online pharmaceutical sales business.</p><p>The Internet and Direct Marketing Retail sector faced broad selling pressure, with peers including Ali Health, PA Good Doctor, JD Group, Alibaba, and Meituan also declining, amplifying the downward move in JD Health's shares.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | JD Health Plummets 5.31% Intraday on GLP-1 Drug Sales Regulations and Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | JD Health Plummets 5.31% Intraday on GLP-1 Drug Sales Regulations and Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-18 10:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare platform.</p><p>New regulations that took effect require purchasers of GLP-1 weight loss drugs to present paper prescriptions issued by physical hospitals, invalidating prescriptions from internet hospitals. This has led multiple pharmacies to delist related products from JD and other platforms, directly suppressing the company's online pharmaceutical sales business.</p><p>The Internet and Direct Marketing Retail sector faced broad selling pressure, with peers including Ali Health, PA Good Doctor, JD Group, Alibaba, and Meituan also declining, amplifying the downward move in JD Health's shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1147798349","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147798349","pubTimestamp":1779069749,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"个股赛道|京东健康盘中暴跌5.31%受GLP-1药品销售监管及板块疲软影响","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare platform.New regulations that took effect require purchasers of GLP-1 weight loss drugs to present paper prescriptions issued by physical hospitals, invalidating prescriptions from internet hospitals. This has led multiple pharmacies to delist related products from JD and other platforms, directly suppressing the company's online pharmaceutical sales business.The Internet and Direct Marketing Retail sector faced broad selling pressure, with peers including Ali Health, PA Good Doctor, JD Group, Alibaba, and Meituan also declining, amplifying the downward move in JD Health's shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}